MYDECINE
About Us
Our Portfolio
Our Story
For Investors
News & Media
Our Leadership
News & Media
Mydecine Innovations Group to Acquire NeuroPharm Inc.
June 10, 2020
Strategically Positioned on Therapies for Military, Veterans, Front-Line Personnel Globally to cope with Mental Health & Well-Being
Read More →
Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health
June 17, 2020
Mydecine Innovations Group Inc. is pleased to announce that it has signed a definitive share exchange agreement with Mindleap Health Inc.
Read More →
Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation
June 15, 2020
Hosted In The University Of Alberta Faculty Of Pharmacy And Pharmaceutical Sciences With Full Access To GMP Capacity And Health Canada Licenses
Read More →
← Back to homepage